SCHEMBL8290949

SCHEMBL8290949

CCCCCC[C@@H](/C=C/N=C=O)CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 2/20 0.34
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH4 P08319 1/20 0.33
ADH7 P40394 1/20 0.33
TRPA1 O75762 1/20 0.33
DDAH1 O94760 1/20 0.33
GAPDH P04406 1/20 0.33
GPR84 Q9NQS5 5/20 0.32
FDPS P14324 3/20 0.32
FFAR1 O14842 1/20 0.32
LCK P06239 1/20 0.31
PPARD Q03181 1/20 0.31
ZDHHC20 Q5W0Z9 1/20 0.31
ZDHHC2 Q9UIJ5 1/20 0.31
LMNA P02545 1/20 0.31
LAP3 P28838 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8291166 0.90 MAPT (0.34) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL13009192 0.85 TSHR (0.33) TSHRSMN1; SMN2
SCHEMBL9253400 0.72 TSHR (0.48) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL11972782 0.71 TSHR (0.46) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL11973209 0.71 TSHR (0.46) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL1506834 0.71 TSHR (0.46) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL1506833 0.71 TSHR (0.46) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL11973211 0.71 TSHR (0.46) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL11972784 0.71 TSHR (0.46) TSHRSMN1; SMN2MAPTADH1BADH1C
SCHEMBL2922631 0.69 TSHR (0.82) TSHRSMN1; SMN2MAPTADH1BADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005073214-A2 NOVEL INHIBITORS OF CHYMASE JANSSEN PHARMACEUTICA, N.V. (BE) 2005-08-11 WO disclosed